Open AccessTopical Administration of 0.3% Tofacitinib Suppresses M1 Macrophage Polarization and Allograft Corneal Rejection by Blocking STAT1 Activation in the Rat Cornea
Author(s) -
Jianfeng Yu,
Pengfei Li,
Zhuang Li,
Yingqi Li,
Jiawei Luo,
Wenru Su,
Dan Liang
Publication year - 2022
Publication title -
translational vision science and technology
Language(s) - English
Resource type - Journals
ISSN - 2164-2591
DOI - 10.1167/tvst.11.3.34
Subject(s) - tofacitinib , medicine , stat1 , pharmacology , macrophage polarization , cancer research , immunology , cornea , macrophage , in vitro , chemistry , interferon , ophthalmology , rheumatoid arthritis , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom